Anticounterfeiting in Pharmaceutical Supply Chain by establishing Proof of Ownership

Raj, Rohit; Rai, Nandini; Agarwal, Sonali

doi:10.1109/tencon.2019.8929271

Cited by 44 publications

(30 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some authors have recently focused on counterfeiting in specific sectors. The authors of [109] proposed a new solution based on blockchain implemented on the Hyperledger Fabric platform for exploring counterfeiting and improving visibility and traceability in the pharma supply chain. The authors of [110] introduced a blockchain-based technology known as counterchain for increasing the authenticity of drugs and consumer confidence in products.…”

Section: Cluster 7: Monitoring Counterfeited Products In the Supply Cmentioning

confidence: 99%

Supply Chain Disruption Risk Management with Blockchain: A Dynamic Literature Review

et al. 2021

View full text Add to dashboard Cite

The purpose of this review is to describe the landscape of scientific literature enriched by an author’s keyword analysis to develop and test blockchain’s capabilities for enhancing supply chain resilience in times of increased risk and uncertainty. This review adopts a dynamic quantitative bibliometric method called systematic literature network analysis (SLNA) to extract and analyze the papers. The procedure consists of two methods: a systematic literature review (SLR) and bibliometric network analysis (BNA). This paper provides an important contribution to the literature in applying blockchain as a key component of cyber supply chain risk management (CSRM), manage and predict disruption risks that lead to resilience and robustness of the supply chain. This systematic review also sheds light on different research areas such as the potential of blockchain for privacy and security challenges, security of smart contracts, monitoring counterfeiting, and traceability database systems to ensure food safety and security.

show abstract

Section: Cluster 7: Monitoring Counterfeited Products In the Supply Cmentioning

confidence: 99%

Supply Chain Disruption Risk Management with Blockchain: A Dynamic Literature Review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Counterfeit drugs also have been addressed by [5,12,20] where authors prevent counterfeiting by proposing a secure, immutable and traceable pharmaceutical supply chain based on blockchain technology.…”

Section: Pharmaceutical Supply Chainmentioning

confidence: 99%

“…In this survey, we present the most relevant researches applying blockchain in healthcare sector. The studied approaches are classified according to a wide range of use cases such as electronic medical records [2,[6][7][8]16,22,25], remote patient monitoring [11,14,21], pharmaceutical supply chain [4,5,12,15,20] and health insurance claims [10,26]. Additionally, this study discusses the applicability of these solutions and their technical limitations.…”

Section: Introductionmentioning

confidence: 99%

Application of Blockchain Technology in Healthcare: A Comprehensive Study

Fekih

Lahami

2020

Lecture Notes in Computer Science

View full text Add to dashboard Cite

Blockchain technology has been emerged in the last decade and has gained a lot of interests from several sectors such as finance, government, energy, health, etc. This paper gives a broad ranging survey of the application of blockchain in healthcare domain. In fact, the ongoing research in this area is evolving rapidly. Therefore, we have identified several use cases in the state of art applying the blockchain technology, for instance for sharing electronic medical records, for remote patient monitoring, for drug supply chain, etc. We have focused also on identifying limitations of studied approaches and finally we have discussed some open research issues and the areas of future research.

show abstract

“…According to Raj et al [6], counterfeit drugs are pharmaceutical products that are manufactured and pushed into the market to deceptively represent the origin, effectiveness and authenticity of a drug. According to the WHO as Raj et al added, counterfeited versions of different drugs worth 80 billion dollars are traded annually worldwide.…”

Section: Introductionmentioning

confidence: 99%

“…In the Nigerian context, Enyinda and Tolliver [11] proposed solutions by leveraging on Multilayer Mitigation Approach encapsulating a cocktail of policy/enforcement and the use of technology. In a broader perspective (not particular to Nigeria), Raj et al [6] proposed a solution by adopting block chain's proof of ownership to increase visibility and transparency in the pharmaceutical supply chain.…”

Section: Introductionmentioning

confidence: 99%

The Nigerian Pharmaceutical Supply Chain: Blockchain Adoption, Counterfeit Drugs and Successful Deployment of COVID-19 Vaccine in Nigeria

Labaran¹,

Hamma-Adama

2021

JSRR

View full text Add to dashboard Cite

Aim: Critically investigating the possibility of adopting blockchain technology within the Nigerian pharmaceutical supply chain to curb the supply of counterfeit drugs. Study Design: The study is qualitative in nature and the primary data were fetched through interviews. Place and Duration of the Study: Conducted within Nigeria for a period of 3 months. Methodology: A qualitative method of data collection was adopted in the study, where some stakeholders were interviewed. The interviews were conducted with employees from different pharmaceutical companies and some drug regulatory agencies in Nigeria. Result: Firstly, this study has ascertained the current prevalence of counterfeit drugs and the reasons for that. The study discovers a very high level of counterfeit drugs and some reasons behind that. Secondly, this study has also found some barriers to blockchain adoption, including the fact that the level of awareness of blockchain technology among stakeholders within the Nigerian pharmaceutical supply chain and the regulatory agencies is very low. Conclusion: It was concluded that the efforts put in developing a viable COVID-19 vaccine could be undermined due to the current nature of the Nigerian pharmaceutical supply chain, the nature of porous borders in place, absence of an apparent drug distribution system, among others. This study also concludes that the supply chain's current structure needs more regulatory and structural interventions by the Nigerian government than blockchain technology. In other words, with the current nature of the supply chain, blockchain technology adoption would not be effective in delivering the said benefits reported by scholars because the atmosphere is not conducive for successful blockchain adoption.

show abstract

Anticounterfeiting in Pharmaceutical Supply Chain by establishing Proof of Ownership

Cited by 44 publications

References 6 publications

Supply Chain Disruption Risk Management with Blockchain: A Dynamic Literature Review

Supply Chain Disruption Risk Management with Blockchain: A Dynamic Literature Review

Application of Blockchain Technology in Healthcare: A Comprehensive Study

The Nigerian Pharmaceutical Supply Chain: Blockchain Adoption, Counterfeit Drugs and Successful Deployment of COVID-19 Vaccine in Nigeria

Contact Info

Product

Resources

About